Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Tanzania center reports improved pediatric cancer detection but survival remains low
Loading...
Summary
Bugando Medical Center reported increased pediatric cancer case detection and broader diagnostic diversity from 2014–2022, with one-year overall survival at 46.4% and median survival 10.5 months; programmatic interventions (registry, hostel, outreach) have improved detection but outcomes remain below WHO targets.
Deborah Jasmine presented retrospective data from Bugando Medical Center (BMC) documenting changes in pediatric cancer detection and outcomes between 2014 and 2022. The study reviewed roughly 1,500 records with survival analysis performed on about 1,000 children from 2016 onward. The three most common diagnoses at BMC were Wilms tumor, Burkitt lymphoma and retinoblastoma, conditions often detectable by visible masses.
Key survival metrics reported included one-year overall survival of 46.4%, two-year overall survival of 35.2%, and a median overall survival of 10.5 months. Event-free survival was lower due to abandonment and relapse (one-year EFS 27.9%, two-year 18.6%). Jasmine attributed improved case detection and diagnostic diversity to sustained outreach, registry development, establishment of a family hostel to reduce abandonment, training of healthcare workers and the institution of tumor boards.
Jasmine stressed that despite progress, survival remains far below the WHO childhood-cancer target of 60% by 2030 and recommended sustained multisector efforts, registry expansion and integration of pediatric cancer into national cancer-control programs.
